17 Capital Partners’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$815K Buy
1,767
+25
+1% +$12.6K 0.42% 86
2025
Q4
$987K Sell
1,742
-94
-5% -$50K 0.51% 68
2025
Q3
$821K Sell
1,836
-205
-10% -$98.4K 0.45% 83
2025
Q2
$1.11M Buy
2,041
+150
+8% +$78.4K 0.64% 54
2025
Q1
$937K Buy
1,891
+40
+2% +$22.1K 0.6% 57
2024
Q4
$966K Buy
1,851
+35
+2% +$18.2K 0.61% 61
2024
Q3
$892K Sell
1,816
-368
-17% -$171K 0.58% 62
2024
Q2
$972K Buy
2,184
+100
+5% +$39.8K 0.69% 53
2024
Q1
$832K Sell
2,084
-50
-2% -$18.9K 0.62% 58
2023
Q4
$720K Buy
+2,134
New +$636K 0.66% 56
2022
Q3
$259K Hold
1,384
0.35% 72
2022
Q2
$278K Hold
1,384
0.35% 78
2022
Q1
$418K Sell
1,384
-1,175
-46% -$343K 0.44% 69
2021
Q4
$919K Hold
2,559
0.84% 45
2021
Q3
$848K Sell
2,559
-270
-10% -$90.7K 0.8% 46
2021
Q2
$867K Buy
+2,829
New +$794K 0.81% 47

Other funds holding ISRG

17 Capital Partners's ISRG Position: Q1 2026 in Review

17 Capital Partners increased its Intuitive Surgical (ISRG) stake by 1.4% in Q1 2026, buying an estimated $12.6K and bringing the position to 1,767 shares worth $815K. The position accounts for 0.42% of the portfolio, ranked #86.

17 Capital Partners first reported a position in ISRG in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.11M in Q2 2025. 2,304 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.

  • 17 Capital Partners held 1,767 shares of Intuitive Surgical worth $815K as of Q1 2026.
  • 17 Capital Partners bought 25 Intuitive Surgical shares in Q1 2026, an estimated $12.6K.
  • Intuitive Surgical made up 0.42% of 17 Capital Partners's portfolio in Q1 2026, its #86 holding.
  • 17 Capital Partners first reported a position in Intuitive Surgical in Q2 2021 and has held it in 16 quarters since.
  • 17 Capital Partners's Intuitive Surgical position peaked at $1.11M in Q2 2025.
  • 2,304 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.

Based on 17 Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.